nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP1A2—Sorafenib—liver cancer	0.137	0.316	CbGbCtD
Cinacalcet—CYP2D6—Sorafenib—liver cancer	0.113	0.26	CbGbCtD
Cinacalcet—CYP3A4—Sorafenib—liver cancer	0.072	0.166	CbGbCtD
Cinacalcet—CYP2D6—Doxorubicin—liver cancer	0.0687	0.158	CbGbCtD
Cinacalcet—CYP3A4—Doxorubicin—liver cancer	0.0437	0.1	CbGbCtD
Cinacalcet—Carcinoma—Sorafenib—liver cancer	0.0238	0.0764	CcSEcCtD
Cinacalcet—Metastatic neoplasm—Epirubicin—liver cancer	0.0138	0.0445	CcSEcCtD
Cinacalcet—Metastatic neoplasm—Doxorubicin—liver cancer	0.0128	0.0411	CcSEcCtD
Cinacalcet—Neoplasm malignant—Sorafenib—liver cancer	0.0084	0.027	CcSEcCtD
Cinacalcet—Multi-organ failure—Epirubicin—liver cancer	0.00813	0.0262	CcSEcCtD
Cinacalcet—Bone disorder—Sorafenib—liver cancer	0.00794	0.0255	CcSEcCtD
Cinacalcet—Hypocalcaemia—Sorafenib—liver cancer	0.00784	0.0252	CcSEcCtD
Cinacalcet—Multi-organ failure—Doxorubicin—liver cancer	0.00753	0.0242	CcSEcCtD
Cinacalcet—Cardiac failure—Sorafenib—liver cancer	0.00534	0.0172	CcSEcCtD
Cinacalcet—Pain in extremity—Sorafenib—liver cancer	0.00521	0.0167	CcSEcCtD
Cinacalcet—Dehydration—Sorafenib—liver cancer	0.00484	0.0156	CcSEcCtD
Cinacalcet—Hypercalcaemia—Epirubicin—liver cancer	0.00382	0.0123	CcSEcCtD
Cinacalcet—Thrombosis—Epirubicin—liver cancer	0.00375	0.012	CcSEcCtD
Cinacalcet—Ventricular arrhythmia—Epirubicin—liver cancer	0.00358	0.0115	CcSEcCtD
Cinacalcet—Hypercalcaemia—Doxorubicin—liver cancer	0.00353	0.0114	CcSEcCtD
Cinacalcet—Thrombosis—Doxorubicin—liver cancer	0.00347	0.0111	CcSEcCtD
Cinacalcet—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00331	0.0107	CcSEcCtD
Cinacalcet—Immune system disorder—Sorafenib—liver cancer	0.00325	0.0105	CcSEcCtD
Cinacalcet—Arrhythmia—Sorafenib—liver cancer	0.00322	0.0103	CcSEcCtD
Cinacalcet—Malnutrition—Sorafenib—liver cancer	0.00314	0.0101	CcSEcCtD
Cinacalcet—Neoplasm malignant—Epirubicin—liver cancer	0.0031	0.00998	CcSEcCtD
Cinacalcet—Muscle spasms—Sorafenib—liver cancer	0.00302	0.0097	CcSEcCtD
Cinacalcet—Bone disorder—Epirubicin—liver cancer	0.00294	0.00944	CcSEcCtD
Cinacalcet—Anaemia—Sorafenib—liver cancer	0.0029	0.00932	CcSEcCtD
Cinacalcet—Hypocalcaemia—Epirubicin—liver cancer	0.0029	0.00931	CcSEcCtD
Cinacalcet—Neoplasm malignant—Doxorubicin—liver cancer	0.00287	0.00924	CcSEcCtD
Cinacalcet—Angioedema—Sorafenib—liver cancer	0.00287	0.00921	CcSEcCtD
Cinacalcet—Cough—Sorafenib—liver cancer	0.00274	0.0088	CcSEcCtD
Cinacalcet—Bone disorder—Doxorubicin—liver cancer	0.00272	0.00873	CcSEcCtD
Cinacalcet—Hypertension—Sorafenib—liver cancer	0.00271	0.00871	CcSEcCtD
Cinacalcet—Hypocalcaemia—Doxorubicin—liver cancer	0.00268	0.00862	CcSEcCtD
Cinacalcet—Arthralgia—Sorafenib—liver cancer	0.00267	0.00859	CcSEcCtD
Cinacalcet—Myalgia—Sorafenib—liver cancer	0.00267	0.00859	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00265	0.00853	CcSEcCtD
Cinacalcet—Dexfenfluramine—CYP2E1—liver cancer	0.00264	0.623	CrCbGaD
Cinacalcet—Infection—Sorafenib—liver cancer	0.00254	0.00818	CcSEcCtD
Cinacalcet—Nervous system disorder—Sorafenib—liver cancer	0.00251	0.00807	CcSEcCtD
Cinacalcet—Skin disorder—Sorafenib—liver cancer	0.00249	0.00799	CcSEcCtD
Cinacalcet—Anorexia—Sorafenib—liver cancer	0.00244	0.00785	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00233	0.0075	CcSEcCtD
Cinacalcet—Dyspnoea—Sorafenib—liver cancer	0.00228	0.00734	CcSEcCtD
Cinacalcet—Dyspepsia—Sorafenib—liver cancer	0.00225	0.00724	CcSEcCtD
Cinacalcet—Decreased appetite—Sorafenib—liver cancer	0.00222	0.00715	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Sorafenib—liver cancer	0.00221	0.00711	CcSEcCtD
Cinacalcet—Fatigue—Sorafenib—liver cancer	0.00221	0.0071	CcSEcCtD
Cinacalcet—Constipation—Sorafenib—liver cancer	0.00219	0.00704	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Sorafenib—liver cancer	0.00209	0.00673	CcSEcCtD
Cinacalcet—Urticaria—Sorafenib—liver cancer	0.00203	0.00654	CcSEcCtD
Cinacalcet—Body temperature increased—Sorafenib—liver cancer	0.00202	0.00651	CcSEcCtD
Cinacalcet—Abdominal pain—Sorafenib—liver cancer	0.00202	0.00651	CcSEcCtD
Cinacalcet—Cardiac failure—Epirubicin—liver cancer	0.00197	0.00634	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00192	0.00619	CcSEcCtD
Cinacalcet—Pain in extremity—Epirubicin—liver cancer	0.00192	0.00619	CcSEcCtD
Cinacalcet—Hypersensitivity—Sorafenib—liver cancer	0.00189	0.00606	CcSEcCtD
Cinacalcet—Asthenia—Sorafenib—liver cancer	0.00184	0.00591	CcSEcCtD
Cinacalcet—Cardiac failure—Doxorubicin—liver cancer	0.00182	0.00587	CcSEcCtD
Cinacalcet—Pruritus—Sorafenib—liver cancer	0.00181	0.00582	CcSEcCtD
Cinacalcet—Dehydration—Epirubicin—liver cancer	0.00179	0.00576	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00178	0.00573	CcSEcCtD
Cinacalcet—Pain in extremity—Doxorubicin—liver cancer	0.00178	0.00573	CcSEcCtD
Cinacalcet—Diarrhoea—Sorafenib—liver cancer	0.00175	0.00563	CcSEcCtD
Cinacalcet—Dizziness—Sorafenib—liver cancer	0.00169	0.00544	CcSEcCtD
Cinacalcet—Dehydration—Doxorubicin—liver cancer	0.00166	0.00533	CcSEcCtD
Cinacalcet—Vomiting—Sorafenib—liver cancer	0.00163	0.00523	CcSEcCtD
Cinacalcet—Rash—Sorafenib—liver cancer	0.00161	0.00519	CcSEcCtD
Cinacalcet—Dermatitis—Sorafenib—liver cancer	0.00161	0.00518	CcSEcCtD
Cinacalcet—Headache—Sorafenib—liver cancer	0.0016	0.00516	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Epirubicin—liver cancer	0.00155	0.00497	CcSEcCtD
Cinacalcet—Nausea—Sorafenib—liver cancer	0.00152	0.00489	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00143	0.0046	CcSEcCtD
Cinacalcet—Oedema peripheral—Epirubicin—liver cancer	0.00131	0.00422	CcSEcCtD
Cinacalcet—Oedema peripheral—Doxorubicin—liver cancer	0.00121	0.0039	CcSEcCtD
Cinacalcet—Immune system disorder—Epirubicin—liver cancer	0.0012	0.00387	CcSEcCtD
Cinacalcet—Arrhythmia—Epirubicin—liver cancer	0.00119	0.00382	CcSEcCtD
Cinacalcet—Malnutrition—Epirubicin—liver cancer	0.00116	0.00373	CcSEcCtD
Cinacalcet—Muscle spasms—Epirubicin—liver cancer	0.00111	0.00358	CcSEcCtD
Cinacalcet—Immune system disorder—Doxorubicin—liver cancer	0.00111	0.00358	CcSEcCtD
Cinacalcet—Arrhythmia—Doxorubicin—liver cancer	0.0011	0.00354	CcSEcCtD
Cinacalcet—Malnutrition—Doxorubicin—liver cancer	0.00107	0.00345	CcSEcCtD
Cinacalcet—Anaemia—Epirubicin—liver cancer	0.00107	0.00344	CcSEcCtD
Cinacalcet—Muscle spasms—Doxorubicin—liver cancer	0.00103	0.00332	CcSEcCtD
Cinacalcet—Cough—Epirubicin—liver cancer	0.00101	0.00325	CcSEcCtD
Cinacalcet—Convulsion—Epirubicin—liver cancer	0.001	0.00323	CcSEcCtD
Cinacalcet—Hypertension—Epirubicin—liver cancer	0.001	0.00322	CcSEcCtD
Cinacalcet—Anaemia—Doxorubicin—liver cancer	0.000991	0.00319	CcSEcCtD
Cinacalcet—Arthralgia—Epirubicin—liver cancer	0.000987	0.00317	CcSEcCtD
Cinacalcet—Chest pain—Epirubicin—liver cancer	0.000987	0.00317	CcSEcCtD
Cinacalcet—Myalgia—Epirubicin—liver cancer	0.000987	0.00317	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00098	0.00315	CcSEcCtD
Cinacalcet—Infection—Epirubicin—liver cancer	0.00094	0.00302	CcSEcCtD
Cinacalcet—Cough—Doxorubicin—liver cancer	0.000936	0.00301	CcSEcCtD
Cinacalcet—Convulsion—Doxorubicin—liver cancer	0.000929	0.00299	CcSEcCtD
Cinacalcet—Nervous system disorder—Epirubicin—liver cancer	0.000928	0.00298	CcSEcCtD
Cinacalcet—Hypertension—Doxorubicin—liver cancer	0.000926	0.00298	CcSEcCtD
Cinacalcet—Skin disorder—Epirubicin—liver cancer	0.000919	0.00295	CcSEcCtD
Cinacalcet—Arthralgia—Doxorubicin—liver cancer	0.000913	0.00294	CcSEcCtD
Cinacalcet—Myalgia—Doxorubicin—liver cancer	0.000913	0.00294	CcSEcCtD
Cinacalcet—Chest pain—Doxorubicin—liver cancer	0.000913	0.00294	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000907	0.00292	CcSEcCtD
Cinacalcet—Anorexia—Epirubicin—liver cancer	0.000902	0.0029	CcSEcCtD
Cinacalcet—Hypotension—Epirubicin—liver cancer	0.000884	0.00284	CcSEcCtD
Cinacalcet—Infection—Doxorubicin—liver cancer	0.000869	0.0028	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000862	0.00277	CcSEcCtD
Cinacalcet—Nervous system disorder—Doxorubicin—liver cancer	0.000858	0.00276	CcSEcCtD
Cinacalcet—Skin disorder—Doxorubicin—liver cancer	0.00085	0.00273	CcSEcCtD
Cinacalcet—Paraesthesia—Epirubicin—liver cancer	0.000849	0.00273	CcSEcCtD
Cinacalcet—Dyspnoea—Epirubicin—liver cancer	0.000843	0.00271	CcSEcCtD
Cinacalcet—Propranolol—CYP1A1—liver cancer	0.000836	0.197	CrCbGaD
Cinacalcet—Anorexia—Doxorubicin—liver cancer	0.000834	0.00268	CcSEcCtD
Cinacalcet—Dyspepsia—Epirubicin—liver cancer	0.000833	0.00268	CcSEcCtD
Cinacalcet—Decreased appetite—Epirubicin—liver cancer	0.000822	0.00264	CcSEcCtD
Cinacalcet—Hypotension—Doxorubicin—liver cancer	0.000818	0.00263	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Epirubicin—liver cancer	0.000817	0.00263	CcSEcCtD
Cinacalcet—Fatigue—Epirubicin—liver cancer	0.000816	0.00262	CcSEcCtD
Cinacalcet—Constipation—Epirubicin—liver cancer	0.000809	0.0026	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000797	0.00256	CcSEcCtD
Cinacalcet—Paraesthesia—Doxorubicin—liver cancer	0.000786	0.00253	CcSEcCtD
Cinacalcet—Dyspnoea—Doxorubicin—liver cancer	0.00078	0.00251	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Epirubicin—liver cancer	0.000773	0.00249	CcSEcCtD
Cinacalcet—Dyspepsia—Doxorubicin—liver cancer	0.00077	0.00248	CcSEcCtD
Cinacalcet—Fluoxetine—ALB—liver cancer	0.000763	0.18	CrCbGaD
Cinacalcet—Decreased appetite—Doxorubicin—liver cancer	0.000761	0.00245	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000756	0.00243	CcSEcCtD
Cinacalcet—Fatigue—Doxorubicin—liver cancer	0.000755	0.00243	CcSEcCtD
Cinacalcet—Urticaria—Epirubicin—liver cancer	0.000751	0.00242	CcSEcCtD
Cinacalcet—Constipation—Doxorubicin—liver cancer	0.000748	0.00241	CcSEcCtD
Cinacalcet—Abdominal pain—Epirubicin—liver cancer	0.000748	0.0024	CcSEcCtD
Cinacalcet—Body temperature increased—Epirubicin—liver cancer	0.000748	0.0024	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Doxorubicin—liver cancer	0.000716	0.0023	CcSEcCtD
Cinacalcet—Hypersensitivity—Epirubicin—liver cancer	0.000697	0.00224	CcSEcCtD
Cinacalcet—Urticaria—Doxorubicin—liver cancer	0.000695	0.00224	CcSEcCtD
Cinacalcet—Abdominal pain—Doxorubicin—liver cancer	0.000692	0.00222	CcSEcCtD
Cinacalcet—Body temperature increased—Doxorubicin—liver cancer	0.000692	0.00222	CcSEcCtD
Cinacalcet—Asthenia—Epirubicin—liver cancer	0.000679	0.00218	CcSEcCtD
Cinacalcet—Pruritus—Epirubicin—liver cancer	0.000669	0.00215	CcSEcCtD
Cinacalcet—Diarrhoea—Epirubicin—liver cancer	0.000647	0.00208	CcSEcCtD
Cinacalcet—Hypersensitivity—Doxorubicin—liver cancer	0.000645	0.00207	CcSEcCtD
Cinacalcet—Asthenia—Doxorubicin—liver cancer	0.000628	0.00202	CcSEcCtD
Cinacalcet—Dizziness—Epirubicin—liver cancer	0.000626	0.00201	CcSEcCtD
Cinacalcet—Pruritus—Doxorubicin—liver cancer	0.000619	0.00199	CcSEcCtD
Cinacalcet—Vomiting—Epirubicin—liver cancer	0.000601	0.00193	CcSEcCtD
Cinacalcet—Diarrhoea—Doxorubicin—liver cancer	0.000599	0.00193	CcSEcCtD
Cinacalcet—Rash—Epirubicin—liver cancer	0.000596	0.00192	CcSEcCtD
Cinacalcet—Dermatitis—Epirubicin—liver cancer	0.000596	0.00192	CcSEcCtD
Cinacalcet—Headache—Epirubicin—liver cancer	0.000593	0.00191	CcSEcCtD
Cinacalcet—Dizziness—Doxorubicin—liver cancer	0.000579	0.00186	CcSEcCtD
Cinacalcet—Nausea—Epirubicin—liver cancer	0.000562	0.00181	CcSEcCtD
Cinacalcet—Vomiting—Doxorubicin—liver cancer	0.000556	0.00179	CcSEcCtD
Cinacalcet—Rash—Doxorubicin—liver cancer	0.000552	0.00177	CcSEcCtD
Cinacalcet—Dermatitis—Doxorubicin—liver cancer	0.000551	0.00177	CcSEcCtD
Cinacalcet—Headache—Doxorubicin—liver cancer	0.000548	0.00176	CcSEcCtD
Cinacalcet—Nausea—Doxorubicin—liver cancer	0.00052	0.00167	CcSEcCtD
Cinacalcet—CYP1A2—Biological oxidations—NR1H4—liver cancer	0.000488	0.00195	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTA1—liver cancer	0.000487	0.00195	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—NAT2—liver cancer	0.000481	0.00193	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTA3—liver cancer	0.00048	0.00192	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000476	0.00191	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—NAT2—liver cancer	0.000475	0.0019	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CG—liver cancer	0.000474	0.0019	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTA3—liver cancer	0.000473	0.00189	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00047	0.00188	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CD—liver cancer	0.000459	0.00184	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.000454	0.00182	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000443	0.00177	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTA4—liver cancer	0.000439	0.00176	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000438	0.00175	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTA4—liver cancer	0.000433	0.00173	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTA2—liver cancer	0.000428	0.00171	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000424	0.0017	CbGpPWpGaD
Cinacalcet—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000423	0.00169	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PRKCE—liver cancer	0.000422	0.00169	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GGT1—liver cancer	0.000417	0.00167	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CD—liver cancer	0.000417	0.00167	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTA1—liver cancer	0.000412	0.00165	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—NAT2—liver cancer	0.000408	0.00163	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000408	0.00163	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.000404	0.00162	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	0.000402	0.00161	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CB—liver cancer	0.0004	0.0016	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IGF2—liver cancer	0.0004	0.0016	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000386	0.00155	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.000385	0.00154	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000377	0.00151	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GSTP1—liver cancer	0.000375	0.0015	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CSF2—liver cancer	0.000373	0.00149	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—RAF1—liver cancer	0.000372	0.00149	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.00037	0.00148	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—H2AFX—liver cancer	0.000368	0.00147	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—IL2—liver cancer	0.000368	0.00147	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000365	0.00146	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CB—liver cancer	0.000363	0.00145	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00036	0.00144	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GSTM1—liver cancer	0.000344	0.00138	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000342	0.00137	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	0.000342	0.00137	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000339	0.00135	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000338	0.00135	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000337	0.00135	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000334	0.00134	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL2—liver cancer	0.000334	0.00134	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TERT—liver cancer	0.000333	0.00133	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.00033	0.00132	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—HPGDS—liver cancer	0.000326	0.0013	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000318	0.00127	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000315	0.00126	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.000314	0.00126	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.00031	0.00124	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	0.000309	0.00124	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000309	0.00124	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000309	0.00124	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KDR—liver cancer	0.000304	0.00122	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000302	0.00121	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAPK14—liver cancer	0.000302	0.00121	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000302	0.00121	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ESR1—liver cancer	0.000296	0.00119	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000294	0.00118	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—F2—liver cancer	0.000293	0.00117	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GGT1—liver cancer	0.000288	0.00115	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000285	0.00114	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—APC—liver cancer	0.00028	0.00112	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CG—liver cancer	0.00028	0.00112	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000277	0.00111	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP2E1—liver cancer	0.000266	0.00106	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000264	0.00106	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—BRAF—liver cancer	0.000263	0.00105	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	0.000262	0.00105	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTP1—liver cancer	0.000259	0.00104	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000257	0.00103	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	0.000255	0.00102	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000252	0.00101	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CD—liver cancer	0.000246	0.000986	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GGT1—liver cancer	0.000244	0.000977	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CA—liver cancer	0.000244	0.000976	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SERPINE1—liver cancer	0.000244	0.000975	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—KRAS—liver cancer	0.000241	0.000965	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000238	0.000952	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000236	0.000946	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000236	0.000944	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.000235	0.000938	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000225	0.000902	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000222	0.00089	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CA—liver cancer	0.000222	0.000887	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.00022	0.000881	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.00022	0.000881	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—RAF1—liver cancer	0.00022	0.00088	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTP1—liver cancer	0.000219	0.000877	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000218	0.000874	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	0.000216	0.000865	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MTOR—liver cancer	0.000215	0.000859	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CB—liver cancer	0.000215	0.000859	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000205	0.000821	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—HRAS—liver cancer	0.000205	0.00082	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000202	0.00081	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CDKN1B—liver cancer	0.000201	0.000806	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTM1—liver cancer	0.000201	0.000806	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—AKT1—liver cancer	0.000199	0.000798	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	0.000199	0.000795	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CASP3—liver cancer	0.000197	0.00079	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL2—liver cancer	0.000197	0.000789	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6—liver cancer	0.000196	0.000785	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000194	0.000778	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCND1—liver cancer	0.000192	0.000769	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—JUN—liver cancer	0.000192	0.000768	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP1A1—liver cancer	0.000191	0.000764	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CTNNB1—liver cancer	0.00019	0.000762	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000188	0.000754	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	0.000188	0.000754	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000187	0.00075	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MMP9—liver cancer	0.000187	0.000747	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CDKN1A—liver cancer	0.000186	0.000744	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000186	0.000743	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAPK8—liver cancer	0.000181	0.000726	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—AKT1—liver cancer	0.000181	0.000724	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000169	0.000677	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—UGDH—liver cancer	0.000169	0.000675	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—liver cancer	0.000168	0.000671	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000167	0.000668	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—STAT3—liver cancer	0.000166	0.000664	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—EPT1—liver cancer	0.000159	0.000634	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000155	0.000622	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MYC—liver cancer	0.000154	0.000617	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TGFB1—liver cancer	0.000154	0.000615	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000153	0.000614	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TAT—liver cancer	0.00015	0.000601	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000147	0.00059	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000145	0.000582	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000143	0.000573	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—UGDH—liver cancer	0.000143	0.000572	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KRAS—liver cancer	0.000142	0.00057	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—EPT1—liver cancer	0.000134	0.000537	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CA—liver cancer	0.000131	0.000524	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TAT—liver cancer	0.000127	0.000509	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—liver cancer	0.000127	0.000507	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000125	0.000501	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HRAS—liver cancer	0.000121	0.000485	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6—liver cancer	0.000116	0.000464	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—UGDH—liver cancer	0.00011	0.000441	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—AKT1—liver cancer	0.000107	0.000428	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—EPT1—liver cancer	0.000104	0.000415	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CPT1B—liver cancer	0.000102	0.000409	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GLUL—liver cancer	0.000102	0.000409	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NR1H4—liver cancer	9.85e-05	0.000394	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TAT—liver cancer	9.82e-05	0.000393	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTA3—liver cancer	9.68e-05	0.000388	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	9.37e-05	0.000375	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTA4—liver cancer	8.86e-05	0.000354	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GLUL—liver cancer	8.65e-05	0.000346	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CPT1B—liver cancer	8.65e-05	0.000346	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTA2—liver cancer	8.63e-05	0.000345	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NR1H4—liver cancer	8.34e-05	0.000334	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTA1—liver cancer	8.33e-05	0.000333	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NAT2—liver cancer	8.23e-05	0.000329	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTA3—liver cancer	8.2e-05	0.000328	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ALDOB—liver cancer	7.89e-05	0.000316	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CRABP1—liver cancer	7.53e-05	0.000301	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTA4—liver cancer	7.5e-05	0.0003	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	7.33e-05	0.000293	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTA2—liver cancer	7.31e-05	0.000293	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTA1—liver cancer	7.05e-05	0.000282	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NAT2—liver cancer	6.98e-05	0.000279	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.71e-05	0.000268	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ALDOB—liver cancer	6.69e-05	0.000268	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CPT1B—liver cancer	6.68e-05	0.000267	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GLUL—liver cancer	6.68e-05	0.000267	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HPGDS—liver cancer	6.58e-05	0.000263	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NR1H4—liver cancer	6.44e-05	0.000258	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CRABP1—liver cancer	6.38e-05	0.000255	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTA3—liver cancer	6.33e-05	0.000253	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PSMD10—liver cancer	5.87e-05	0.000235	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PSMA4—liver cancer	5.87e-05	0.000235	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTA4—liver cancer	5.79e-05	0.000232	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.74e-05	0.00023	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GOT2—liver cancer	5.71e-05	0.000228	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTA2—liver cancer	5.64e-05	0.000226	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HPGDS—liver cancer	5.58e-05	0.000223	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.54e-05	0.000222	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTA1—liver cancer	5.44e-05	0.000218	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NAT2—liver cancer	5.38e-05	0.000215	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP2E1—liver cancer	5.37e-05	0.000215	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ALDOB—liver cancer	5.16e-05	0.000207	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.05e-05	0.000202	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYCS—liver cancer	5.02e-05	0.000201	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.98e-05	0.000199	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PSMD10—liver cancer	4.97e-05	0.000199	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PSMA4—liver cancer	4.97e-05	0.000199	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GGT1—liver cancer	4.93e-05	0.000197	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GOT1—liver cancer	4.93e-05	0.000197	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CRABP1—liver cancer	4.92e-05	0.000197	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GOT2—liver cancer	4.83e-05	0.000193	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP2E1—liver cancer	4.55e-05	0.000182	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTP1—liver cancer	4.43e-05	0.000177	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.4e-05	0.000176	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HMOX1—liver cancer	4.36e-05	0.000175	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HPGDS—liver cancer	4.3e-05	0.000172	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYCS—liver cancer	4.25e-05	0.00017	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GOT1—liver cancer	4.17e-05	0.000167	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GGT1—liver cancer	4.17e-05	0.000167	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTM1—liver cancer	4.07e-05	0.000163	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP1A1—liver cancer	3.86e-05	0.000154	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PSMD10—liver cancer	3.84e-05	0.000153	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PSMA4—liver cancer	3.84e-05	0.000153	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTP1—liver cancer	3.75e-05	0.00015	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GOT2—liver cancer	3.73e-05	0.000149	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HMOX1—liver cancer	3.7e-05	0.000148	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MTHFR—liver cancer	3.59e-05	0.000144	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PPARA—liver cancer	3.53e-05	0.000141	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP2E1—liver cancer	3.51e-05	0.00014	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTM1—liver cancer	3.44e-05	0.000138	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYCS—liver cancer	3.28e-05	0.000131	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP1A1—liver cancer	3.27e-05	0.000131	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GGT1—liver cancer	3.22e-05	0.000129	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GOT1—liver cancer	3.22e-05	0.000129	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTHFR—liver cancer	3.04e-05	0.000122	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CG—liver cancer	3.02e-05	0.000121	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PPARA—liver cancer	2.99e-05	0.00012	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PPARG—liver cancer	2.91e-05	0.000117	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTP1—liver cancer	2.89e-05	0.000116	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HMOX1—liver cancer	2.85e-05	0.000114	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.68e-05	0.000107	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTM1—liver cancer	2.66e-05	0.000106	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CD—liver cancer	2.65e-05	0.000106	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ALB—liver cancer	2.62e-05	0.000105	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CG—liver cancer	2.56e-05	0.000102	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP1A1—liver cancer	2.52e-05	0.000101	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PPARG—liver cancer	2.47e-05	9.88e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTHFR—liver cancer	2.35e-05	9.4e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CB—liver cancer	2.31e-05	9.26e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PPARA—liver cancer	2.31e-05	9.22e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CD—liver cancer	2.25e-05	9e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ALB—liver cancer	2.22e-05	8.88e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CG—liver cancer	1.97e-05	7.9e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CB—liver cancer	1.96e-05	7.84e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PPARG—liver cancer	1.91e-05	7.62e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CD—liver cancer	1.74e-05	6.95e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ALB—liver cancer	1.71e-05	6.86e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CB—liver cancer	1.51e-05	6.05e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CA—liver cancer	1.41e-05	5.64e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CA—liver cancer	1.19e-05	4.78e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AKT1—liver cancer	1.15e-05	4.61e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AKT1—liver cancer	9.76e-06	3.91e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CA—liver cancer	9.22e-06	3.69e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AKT1—liver cancer	7.53e-06	3.01e-05	CbGpPWpGaD
